Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Amitiza

Lubiprostone

Open in the dashboard

Part D claims

1,085

Prescriptions dispensed, refills included

Drug cost

$314,327

Paid at the pharmacy, in all

Prescribers

76

With 11 or more claims of it

In 2024, Medicare Part D recorded 1,085 claims for Amitiza (lubiprostone) from 76 prescribers, at a total drug cost of $314,327 paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 27 states and territories
Part D claims for Amitiza by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
NY 11 194 $61,451
CA 12 194 $53,439
PA 9 121 $31,470
GA 4 49 $14,182
MN 3 42 $15,001
MO 3 38 $13,385
TX 3 37 $9,210
KS 2 36 $7,381
NC 3 36 $13,876
NJ 2 36 $7,002
OH 3 34 $7,214
AK 2 34 $5,112
MD 2 25 $4,536
NE 2 25 $9,239
VA 2 25 $6,768
The other 12 states and territories
State Prescribers Claims Drug cost
FL 2 22 $8,725
NM 1 14 $5,404
WI 1 13 $4,941
VT 1 13 $4,564
TN 1 13 $5,004
AR 1 13 $1,993
KY 1 13 $4,829
HI 1 12 $2,454
CT 1 12 $7,864
IL 1 12 $5,440
NH 1 11 $1,853
MI 1 11 $1,987

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 10 of 10
Part D claims for Amitiza by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Internal Medicine 22 360 $99,298
Family Practice 18 227 $60,255
Nurse Practitioner 15 190 $63,424
Gastroenterology 10 141 $48,634
General Practice 3 65 $14,251
Physician Assistant 4 52 $16,833
Pulmonary Disease 1 13 $5,281
Emergency Medicine 1 13 $3,122
Psychiatry & Neurology 1 12 $774
Pain Management 1 12 $2,454

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 76 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Victor Lyapis General Practice CA 38 $9,003 None on record
Gopal Narasimhan Internal Medicine NY 28 $6,751 None on record
Dina Sverdlov Internal Medicine CA 24 $6,854 None on record
Jacquelin Holubka Internal Medicine NJ 24 $4,674 None on record
Mouhanad Al-Fakih Internal Medicine PA 24 $2,359 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 76 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for lubiprostone

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record